472 related articles for article (PubMed ID: 18755270)
1. Quality by design - Spray drying of insulin intended for inhalation.
Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
[TBL] [Abstract][Full Text] [Related]
2. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
You Y; Zhao M; Liu G; Tang X
J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
[TBL] [Abstract][Full Text] [Related]
3. Spray-drying process optimization for manufacture of drug-cyclodextrin complex powder using design of experiments.
Nekkanti V; Muniyappan T; Karatgi P; Hari MS; Marella S; Pillai R
Drug Dev Ind Pharm; 2009 Oct; 35(10):1219-29. PubMed ID: 19555246
[TBL] [Abstract][Full Text] [Related]
4. The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation.
Ståhl K; Claesson M; Lilliehorn P; Lindén H; Bäckström K
Int J Pharm; 2002 Feb; 233(1-2):227-37. PubMed ID: 11897427
[TBL] [Abstract][Full Text] [Related]
5. Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process.
Gonnissen Y; Gonçalves SI; De Geest BG; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2008 Mar; 68(3):760-70. PubMed ID: 17964129
[TBL] [Abstract][Full Text] [Related]
6. Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs.
Tewa-Tagne P; Degobert G; Briançon S; Bordes C; Gauvrit JY; Lanteri P; Fessi H
Pharm Res; 2007 Apr; 24(4):650-61. PubMed ID: 17318421
[TBL] [Abstract][Full Text] [Related]
7. Development of a spray congealing process for the preparation of insulin-loaded lipid microparticles and characterization thereof.
Maschke A; Becker C; Eyrich D; Kiermaier J; Blunk T; Göpferich A
Eur J Pharm Biopharm; 2007 Feb; 65(2):175-87. PubMed ID: 17070025
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles.
Kawakami K; Sumitani C; Yoshihashi Y; Yonemochi E; Terada K
Int J Pharm; 2010 May; 390(2):250-9. PubMed ID: 20170721
[TBL] [Abstract][Full Text] [Related]
9. Optimisation of spray drying process conditions for sugar nanoporous microparticles (NPMPs) intended for inhalation.
Amaro MI; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Dec; 421(1):99-109. PubMed ID: 21963473
[TBL] [Abstract][Full Text] [Related]
10. Statistical modeling of protein spray drying at the lab scale.
Prinn KB; Costantino HR; Tracy M
AAPS PharmSciTech; 2002; 3(1):E4. PubMed ID: 12916957
[TBL] [Abstract][Full Text] [Related]
11. Design space approach in the optimization of the spray-drying process.
Lebrun P; Krier F; Mantanus J; Grohganz H; Yang M; Rozet E; Boulanger B; Evrard B; Rantanen J; Hubert P
Eur J Pharm Biopharm; 2012 Jan; 80(1):226-34. PubMed ID: 21983606
[TBL] [Abstract][Full Text] [Related]
12. Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
Bouchard A; Jovanović N; de Boer AH; Martín A; Jiskoot W; Crommelin DJ; Hofland GW; Witkamp GJ
Eur J Pharm Biopharm; 2008 Sep; 70(1):389-401. PubMed ID: 18534833
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in-line spatial filter velocimetry as PAT monitoring tool for particle growth during fluid bed granulation.
Burggraeve A; Van Den Kerkhof T; Hellings M; Remon JP; Vervaet C; De Beer T
Eur J Pharm Biopharm; 2010 Sep; 76(1):138-46. PubMed ID: 20554021
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
Minne A; Boireau H; Horta MJ; Vanbever R
Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
[TBL] [Abstract][Full Text] [Related]
15. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
Thi TH; Danède F; Descamps M; Flament MP
Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
[TBL] [Abstract][Full Text] [Related]
16. Cyclone selection influences protein damage during drying in a mini spray-dryer.
Bögelein J; Lee G
Int J Pharm; 2010 Nov; 401(1-2):68-71. PubMed ID: 20887779
[TBL] [Abstract][Full Text] [Related]
17. Quality by design approach to understand the process of nanosuspension preparation.
Verma S; Lan Y; Gokhale R; Burgess DJ
Int J Pharm; 2009 Jul; 377(1-2):185-98. PubMed ID: 19446617
[TBL] [Abstract][Full Text] [Related]
18. Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy.
Lee SH; Heng D; Ng WK; Chan HK; Tan RB
Int J Pharm; 2011 Jan; 403(1-2):192-200. PubMed ID: 20951781
[TBL] [Abstract][Full Text] [Related]
19. Optimization of Ciprofloxacin Hydrochloride Spray-Dried Microparticles for Pulmonary Delivery Using Design of Experiments.
Razuc M; Piña J; Ramírez-Rigo MV
AAPS PharmSciTech; 2018 Oct; 19(7):3085-3096. PubMed ID: 30105497
[TBL] [Abstract][Full Text] [Related]
20. Quality by design - Spray drying of ciprofloxacin-quercetin fixed-dose combination intended for inhalation.
Alhajj N; O'Reilly NJ; Cathcart H
Int J Pharm; 2023 Jul; 642():123151. PubMed ID: 37364778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]